Tag Archives: Trump&#039s

Pharma CEOs enthuse about Trump's plan to shake up drug rebates

Sweep out drug rebates for patient discounts instead? Big Pharma CEOs are all over it. A week after the Trump administration proposed ending drug rebates in federal health programs—and then urged Congress to extend that plan to commercial insurance—supply chain players are hitting back. The pharmacy benefit manager (PBM) industry has even launched an ad campaign.… Read More »